FULC Shares Outstanding History
Below is a table of the FULC shares outstanding history going back to 7/18/2019:

Date FULC Shares Outstanding
7/18/201923.34M
8/23/201923.34M
9/6/201935.76M
11/8/201923.34M
2/28/202023.36M
5/8/202023.37M
8/4/202027.45M
11/4/202027.46M
2/25/202132.67M
4/29/202132.68M
8/3/202132.71M
10/28/202140.55M
2/24/202240.64M
5/2/202240.85M
8/4/202241.01M
11/1/202252.05M

Also see: FULC Market Cap History
FULC YTD Return
FULC Historical Shares Outstanding:
+27.58% CAGR
FULC Historical Shares Outstanding: +27.58% CAGR

Mouse over chart for data details
7/18/2019 ...11/1/2022
Fulcrum Therapeutics is a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases. Co. has developed a proprietary product engine, FulcrumSeek, that it employs to systematically identify and validate cellular drug targets. Co.' products include: losmapimod, a small molecule that it is developing for the treatment of facioscapulohumeral muscular dystrophy, a rare, progressive and disabling disorder characterized by muscle degeneration and fat infiltration; and FTX-6058, an investigational oral fetal hemoglobin, inducer that is in development for sickle cell disease and select other hemoglobinopathies, including ß-thalassemia. We show 16 historical shares outstanding datapoints in our coverage of FULC's shares outstanding history.

Understanding the changing numbers of FULC shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like FULC versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching FULC by allowing them to research FULC shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree FULC Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Fulcrum Therapeutics (FULC) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

FVE Shares Outstanding History
FWBI Shares Outstanding History
GALT Shares Outstanding History
GANX Shares Outstanding History
GB Shares Outstanding History
GBIO Shares Outstanding History
GBS Shares Outstanding History
GBT Shares Outstanding History
GCTK Shares Outstanding History
GEG Shares Outstanding History
More Healthcare companies »

 

FULC Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2023, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.